Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL
Umbilical cord mesenchymal stem cells
Trial Locations (1)
Unknown
Stem Cell Institute, Panama City
All Listed Sponsors
lead
Translational Biosciences
INDUSTRY
NCT02034188 - Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter